With the FTSE 100 hitting new highs last month, Mark Hartley considers where global stock markets may be heading next – and ...

GSK ( GSK) reported Q3 results that beat on both lines and updated its earnings growth projection for 2025. HSBC ( HSBC) raised its income outlook and pledged growth, despite a Q3 profit hit from ...

The UK's FTSE 100 index reached a new high, driven by positive earnings forecasts from GSK and Next. GSK's stock surged, ...

Stock markets hit record highs Wednesday thanks to optimism over US trade deals, the AI sector and an expected interest-rate ...

The UK's benchmark index closed at a new high on Wednesday, marking its fifth straight record-breaking session, primarily driven by strong earnings forecasts from drugmaker GSK and retailer Next.

The FTSE 100 index was up 72.49 points, 0.8%, at 9,769.23. The FTSE 250 was up 46.37 points, 0.2%, at 22,530.49, and the AIM All-Share was up 4.98 points, 0.7%, at 775.77.

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, ...

(Alliance News) - GSK raises its outlook for revenue and profit, Next ups its guidance as third quarter sales beat expectations, while Primary Health Properties' acquisition of Assura is cleared by ...

(Alliance News) - GSK PLC on Tuesday announced a double dose of good news regarding shingles drug, Shingrix, and urinary tract infection treatment, tebipenem HBr. The London-based pharmaceuticals ...

Investing.com -- GSK plc (LSE:GSK) announced Tuesday that its Shingrix vaccine has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) ...

(Reuters) -The UK's drugs cost-effectiveness watchdog has given a positive recommendation for ViiV Healthcare's HIV drug, enabling access to the preventive medicine via the state health system in ...